← Back to Search

Beta Blocker

Metoprolol Tartrate for Heart Disease (ORION Trial)

Phase 3
Waitlist Available
Led By Peter Nagele, MD
Research Sponsored by University of Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-year from surgery
Awards & highlights

ORION Trial Summary

This trial will test if metoprolol can reduce heart complications in patients with CAD.

ORION Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-year from surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1-year from surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduction of Myocardial Injury following Post-op Beta-blocker therapy
Secondary outcome measures
Incidence of Clinically Relevant Bradycardia
Length of Post-operative Hospitalization
Monitor Post-operative Myocardial ischemia
+5 more
Other outcome measures
Adverse Events

ORION Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: MetoprololExperimental Treatment1 Intervention
Metoprolol group, 3-intravenous doses of 5mg metoprolol tartrate (over 15-minutes), and oral dose(s) of 25mg metoprolol approximately every 8 hours postoperatively for up to 3-days (or 72 hrs).
Group II: PlaceboPlacebo Group1 Intervention
Placebo comparator group, up-to-three intravenous doses of placebo comparator (over 15-minutes), and oral dose(s) of a placebo comparator approximately every 8 hours postoperatively for up to 3-days (or 72 hrs).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Metoprolol
FDA approved

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,837 Previous Clinical Trials
47,851,457 Total Patients Enrolled
University of ChicagoLead Sponsor
1,004 Previous Clinical Trials
819,607 Total Patients Enrolled
Washington University School of MedicineOTHER
1,935 Previous Clinical Trials
2,299,640 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the FDA's stance on Metoprolol Tartrate?

"There is some evidence of efficacy and multiple reports of safety, so Metoprolol Tartrate was given a score of 3."

Answered by AI

What precedent exists for using Metoprolol Tartrate therapeutically?

"As of today, there are 22 ongoing clinical trials studying the effects of Metoprolol Tartrate. 4 of these studies have reached Phase 3. The majority of research locations for Metoprolol Tartrate are situated in Orlando, Florida; though, altogether, 146 different centres are running active Metoprolol Tartrate trials."

Answered by AI

How is Metoprolol Tartrate most often used?

"Metoprolol Tartrate can help patients who suffer from angina pectoris, atrial fibrillation, and other conditions that cause instability in the cardiovascular system."

Answered by AI

How many enrollees does this research project have at present?

"This particular trial is no longer seeking new participants. The study was first posted on December 1st, 2016 and received its latest update on April 20th, 2018. However, if you are interested in other trials, there are currently 340 studies actively recruiting patients with heart diseases and 22 trials for Metoprolol Tartrate that have open enrolment."

Answered by AI

Are patients currently being enrolled in this trial?

"This study isn't enrolling at the moment. The listing was first posted on December 1st, 2016 and edited most recently on April 20th, 2018. However, there are presently 340 trials actively looking for participants with heart diseases and 22 trials for Metoprolol Tartrate that need patients."

Answered by AI
~20 spots leftby Apr 2025